https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-11-05 11:26:472025-11-05 11:35:40ObesityWeek 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-11-05 11:25:482025-11-05 11:32:30Diazoxide Choline Extended-Release for Hyperphagia of Non-Obese/Non-Overweight Patients with PWS
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-11-05 11:25:262025-11-05 11:26:41Diazoxide Choline Extended-Release (DCCR) Improves Hyperphagia in Both Children and Adults with PWS
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-07-14 12:40:392025-07-14 16:13:09The Glycemic Outcomes of Diazoxide Choline Extended-Release (DCCR) Tablets Administered for Hyperphagia in Individuals with Prader-Willi Syndrome Over 4 Years
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-07-14 12:00:212025-07-14 12:54:13Characterization of Peripheral Edema in Individuals with Prader-Willi Syndrome During Long-term Administration of Diazoxide Choline Extended-Release Tablet (DCCR) Over 4.5 Years
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-07-14 09:00:162025-08-22 06:33:56Endocrine Society Annual Meeting (ENDO) 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:562025-06-23 20:28:49Diazoxide Choline Extended-Release (DCCR) Tablets Significantly Reduce Hyperphagia in Patients with PWS who are Managed with Strict Food Controls
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:472025-06-23 20:24:40The Emotional Impact of Hyperphagia: Insights from the Prader-Willi Syndrome Community
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:422025-06-23 20:29:20Comparison of Changes in Fat Mass in Participants with PWS Treated with DCCR to Those in the NIH Natural History Study
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:342025-06-23 20:29:51Swallowability and Dosing Compliance of Diazoxide Choline Extended-Release Tablets in Patients with Prader-Willi Syndrome
